Skip to main content
SpringerLink
Log in

Low-dose prednisolone/chlorambucil therapy in patients with severe membranous glomerulonephritis

  • Original Article
  • Published:
The clinical investigator Aims and scope Submit manuscript

Abstract

Because of the high rate of spontaneous remission, treatment of membranous nephropathy with prednisolone and chlorambucil is still controversial. The aim of this study was to give this therapy only to those patients at risk of developing renal insufficiency and to test the efficacy of a low-dose therapeutic regimen. Seventeen patients with more than 10 g protein excretion per day (mean 16.9) and/or a deterioration in renal function (mean serum creatinine, 162 μmol/l) were included. Serum total protein, serum lipids, proteinuria, serum creatinine, and blood pressure were measured, along with the diuretic and antihypertensive medication. The observation time before the start of treatment was 27 ± 27 months. Steroids were given during months 1, 3, and 5 (methylprednisolone 3 × 500 mg intravenously) prednisolone 0.5 mg/kgBW daily per os for 1 week, then tapered by 0.1 mg/kg BW/week for 1 month. Chlorambucil was given during months 2, 4, and 6 at a dose of 0.12 mg/kgBW daily. At the end of treatment proteinuria had significantly decreased (mean of all patients, 7.8 ± 1.4 g/d) in all patients. Six months after the end of treatment proteinuria was significantly lower than at baseline in 14 of 17 patients. Hypoproteinemia and hyperlipidemia had improved; diuretic and antihypertensive medication were reduced. Elevated serum creatinine decreased in 7 of 9 patients (pretreatment, 227 ± 39 μmol/1; 6 months, 176 ± 28 μmol/l). Nonresponders with respect to serum creatinine responded with respect to proteinuria. Regarding adverse effects, two patients complained of dyspepsia while taking steroids; during chlorambucil treatment two patients experienced nausea and lack of appetite, and one developed leukopenia (1600/μl). Chlorambucil was stopped and cell counts normalized 2 weeks later. We conclude that low-dose prednisolone/chlorambucil is both safe and efficient in the majority of patients with severe membranous nephropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

MGN:

membranous glomerulonephritis

References

  1. Bolton WK, Atuk NO, Sturgill BC, Westervelt FB (1977) Therapy of the idiopathic nephrotic syndrome with alternate day steroids. Am J Med 62:60–70

    Google Scholar 

  2. Cameron JS (1992) Membranous nephropathy — still a treatment dilemma (editorial; comment). N Engl J Med 327:638–639

    Google Scholar 

  3. Cameron JS, Healy MJ, Adu D (1990) The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party (comments). Q J Med 74:133–156

    Google Scholar 

  4. Cattran DC (1991) Current status of cyclosporin A in the treatment of membranous, IgA and membranoproliferative glomerulonephritis. Clin Nephrol 35:7–15

    Google Scholar 

  5. Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S (1989) A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 320:210–215

    Google Scholar 

  6. Ehrenreich J, Churg J (1968) Pathology of membranous nephropathy. Pathol Ann 3:145–151

    Google Scholar 

  7. Davison AM, Kerr DNS, Ogg CS, Wilkinson RW (1984) The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 22:61–67

    Google Scholar 

  8. Donadio JV, Torres VE, Velosa JA (1988) Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int 33:708–715

    Google Scholar 

  9. Jacobs C, Brunner FP, Chantler C (1977) Combined report on regular dialysis and transplantation in Europe, VII, 1976. Proc Eur Dial Transplant Assoc 14:3–69

    Google Scholar 

  10. Lagrue G, Bernard D, Bariety JD, Druet P, Guenel J (1975) Traitement par le chlorambucil et l'azathioprine dans les glomérulonéphrites primitives: résultats d'une étude “con-ntrôlee”. J Urol Nephrol 81:655–672

    Google Scholar 

  11. Lewes EJ (1993) Idiopathic membranous nephropathy —to treat or not to treat? (editorial). N Engl J Med 329:127–129

    Google Scholar 

  12. Mathieson PW, Turner AN, Maidment CG, Evans DJ, Rees AJ (1988) Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function. Lancet 11:869–872

    Google Scholar 

  13. Murphy BF, McDonald I, Fairley KF, Kincaid SP (1992) Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis. Clin Nephrol 37:229–234

    Google Scholar 

  14. Pei Y, Cattran D, Greenwood C (1992) Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 42:960–966

    Google Scholar 

  15. Pierides AM, Malasit P, Morley AR, Wilkinson R, Uldall PR, Kerr DN (1977) Idiopathic membranous nephropathy. Q J Med 46:163–177

    Google Scholar 

  16. Ponticelli C, Passerini P (1991) Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults. Clin Nephrol 35:21–26

    Google Scholar 

  17. Ponticelli C, Zucchelli P, Passerine P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B, et al (1989) A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320:8–13

    Google Scholar 

  18. Ponticelli C, Zucchelli P, Passerini P, Cesana B (1992) Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group (comments). N Engl J Med 327:599–603

    Google Scholar 

  19. Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G (1993) Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 329:85–89

    Google Scholar 

  20. Suki WN, Chavez A (1981) Membranous nephropathy: response to steroids and immunosuppression. Am J Nephrol 1:11–16

    Google Scholar 

  21. Wehrmann M, Bohle A, Bogenschutz O, Eissele R, Freislederer A, Ohlschlegel C, Schumm G, Batz C, Gartner HV (1989) Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol 31:67–76

    Google Scholar 

  22. West ML, Jindal KK, Bear RA, Goldstein MB (1987) A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis. Kidney Int 32:579–584

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Nephrologie, Medizinische Hochschule Hannover, Konstanty-Gutschow-Strasse 8, D-30625, Hannover, Germany

    R. Brunkhorst, E. Wrenger & K. M. Koch

Authors
  1. R. Brunkhorst
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Wrenger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. M. Koch
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Correspondence to: R. Brunkhorst

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brunkhorst, R., Wrenger, E. & Koch, K.M. Low-dose prednisolone/chlorambucil therapy in patients with severe membranous glomerulonephritis. Clin Investig 72, 277–282 (1994). https://doi.org/10.1007/BF00180040

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00180040

Key words

Search

Navigation